IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.
Want to stay updated?Subscribe to our newsletter

Sector
Materials
Filed
May 26, 2026
Varsal Tech, Inc.
Varsal Tech develops and supplies ISO-certified and GMP-compliant chemicals, intermediates and other customized product solutions that are supported by proprietary know-how and deep domain and product expertise.
Through decades of technological development, we have established a business that serves a diversified and global customer base in the pharmaceutical, electronics, industrial, personal care and research markets.
Ticker, listing venue and issuer profile
Pricing terms and IPO milestones
Historical financial performance
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| S-1 | May 26, 2026 | General form for registration of securities under the Securities Act of 1933 |
| DRS/A | Apr 15, 2026 | [Amend] [Cover] Draft Registration Statement |
| DRS | Feb 13, 2026 | [Cover] Draft Registration Statement |
Contact and headquarters details
Key executives and officers
Dr. Pingxin Wang
Chairman, Chief Executive Officer
Dongwei Wang
Interim Chief Financial Officer, Director
Ken Federman
Director nominee
Jerry Lewin
Director nominee
George Lovas
Director nominee